Code assignment supports billing clarity and claims reporting for Imbed's synthetic antimicrobial wound matrix with localized, non-opioid pain management MIDDLETON, Wis., April 1, 2026 /PRNewswire/ -- ...
Please provide your email address to receive an email when new articles are posted on . In this Healio video exclusive, George Martin, MD, discusses highlights from Maui Derm NP+PA, including a new ...
MIDDLETON, Wis.--(BUSINESS WIRE)--Imbed Biosciences announces U.S. Food and Drug Administration 510(k) clearance to market Microlyte® Ag/Lidocaine, the first antimicrobial wound dressing to integrate ...
SARASOTA, Fla., June 6, 2024 /PRNewswire/ -- Omeza ®, a regenerative skincare company that develops marine-based therapies for wounds that are hard to treat, today announced completion of a ...
MADISON, Wis.--(BUSINESS WIRE)--Imbed Biosciences, Inc. (Imbed) announced today that it has been awarded a contract for $1,999,481 by the U.S. Army Medical Research and Development Command’s (USAMRDC) ...
MIDDLETON, Wis., Aug. 28, 2025 /PRNewswire/ -- Imbed Biosciences Inc., a leader in advanced wound care technology, today announced the launch of SAM™ PainGuard™ with Lidocaine, a groundbreaking ...
VALENCIA, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (RCEL) (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound ...
"Assignment of an HCPCS A‑code is an important step in supporting appropriate billing for Microlyte ® PainGuard™," said Terry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results